Cite
HARVARD Citation
Grote, I. et al. (2021). TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine. pp. 8581-8594. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grote, I. et al. (2021). TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine. pp. 8581-8594. [Online].